Volume 7 No 4 1936 1937

Page 1

T he University of W estern Ontario

MEDICAL JOURNAL

/

No. 4

VOL. VII.

Some Experiences with Protamine and Protamine Zinc Insulin 路=路 By J. L. MACARTHUR, '37 discovery of insulin in 1922, by Banting and Best/ ushered in T HEa new era in the treatment of diabetes mellitus. In the past, the cause of death had been diabetic coma, and the prognosis in any case was poor. Since the introduction of insulin, however, there has been a remarkable change. Today, death from coma is uncommon; the prognosis is exceedingly better, especially in the younger and middle-aged groups of patients, and the life span of the diabetic approaches and, in some cases, surpasses that of the non-diabetic individual. Nevertheless, the outlook is not quite as optimistic as it may appear. At present, arteriosclerosis and all its implications, heads the list as the greatest contributing factor causing death among diabetics; and infection is always a serious complication. The subcutaneous injection of insulin cannot compensate wholly for the physiological secretion of the islets of Langerhans. Its action is rapid, powerful and transient; and is likely to be accompanied by mar ked fluctuations in the concentration of the blood sugar. Consequently, sudden and frequent demands are made upon the suprarenal glands when hypoglycaemia ensues. It has been stated 2 that in a moderately severe diabetic, even when the disease is controlled as well as possible, that during one-quarter to one-half of the time the blood sugar is abnormal. This means that during a period of 20 years, hyperglycaemia with its ill effects has been present for from five to ten years. To more closely simulate the physiological secretion, there hould be a slower, steadier flow of insulin into the blood stream. With standard insulin, frequent, repeated, small injections act much more efficiently t han when the total quantity is given as one dose. A prolongation of t he insulin effect has been attempted in two principle ways: (1) By the purification of the insulin to heighten its effects, and (2) by the addition of some substance with which the insulin would combine to form a fairly insoluble compound which, when injected subcutaneously, would break down and liberate insulin to the blood gradually. *From the Department of Pathological Chemistry, University of Western Ontario Medical School.

131


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.